Skip to main content

Table 3 TAFI and F 1 + 2 levels by gender, age, BMI and stage in the gastric cancer group

From: Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

 

TAFI Level

P-value

F 1 + 2 Level

P-value

Gender

Female

63.6 ± 22.7

0.32

483.7 ± 230.8

0.28

 

Male

73.6 ± 39.1

 

598.3 ±379.2

 

Age

>60 (n = 21)

67.7 ± 32.1

0.52

614 ± 337.8

0.11

 

≤60 (n = 12)

73.5 ± 37.1

 

437.2 ± 280.5

 

BMI

>25 (n = 15)

65.7 ± 31.8

0.34

583.7 ± 328.7

0.47

 

≤25 (n = 18)

74.8 ± 34.8

 

521.3 ± 329.1

 

Stages

Stage 1a (n = 1)

93.3

0.92

484

0.81

Stage 1b (n = 0)

-

 

-

 

Stage 2 (n = 5)

68.2 ± 21.3

 

416.8 ± 80.9

 

Stage 3a (n = 14)

69 ± 23.

 

609.5 ± 354.7

 

Stage 3b (n = 4)

71.8 ± 34

 

575 ± 498.7

 
 

Stage 4 (n = 9)

66.9 ± 51.9

 

526.6 ± 321